(Q37035477)

English

Stratified analyses for selecting appropriate target patients with diabetic peripheral neuropathy for long-term treatment with an aldose reductase inhibitor, epalrestat

scientific article published on July 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Stratified analyses for selecting appropriate target patients with diabetic peripheral neuropathy for long-term treatment with an aldose reductase inhibitor, epalrestat (English)

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

peripheral neuropathy

1 reference

based on heuristic

inferred from title

author name string

N Hotta

1

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

R Kawamori

2

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Y Atsumi

3

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

M Baba

4

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

H Kishikawa

5

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

J Nakamura

6

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

S Oikawa

7

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

N Yamada

8

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

H Yasuda

9

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Y Shigeta

10

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

ADCT Study Group

11

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

publication date

1 July 2008

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Diabetic Medicine

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

25

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

7

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

818-825

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: the 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613255

29 September 2017

Treatments for diabetic neuropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613255

29 September 2017

Polyol pathway and diabetic peripheral neuropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613255

29 September 2017

Association between antihypertensive drug use and hypoglycemia: a case-control study of diabetic users of insulin or sulfonylureas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613255

29 September 2017

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613255

29 September 2017

Effects of a Novel Aldose Reductase Inhibitor, Fidarestat (SNK-860), on Vibration Perception Threshold and Subjective Symptoms in Patients with Diabetic Polyneuropathy : An Open-Label Pilot Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613255

27 June 2018

New concepts and insights on pathogenesis and treatment of diabetic complications: polyol pathway and its inhibition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613255

27 June 2018

The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613255

4 September 2018

Long-term effects of ranirestat (AS-3201) on peripheral nerve function in patients with diabetic sensorimotor polyneuropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613255

4 September 2018

Efficacy of glimepiride in Japanese type 2 diabetic subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613255

4 September 2018

Vascular risk factors and diabetic neuropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613255

4 September 2018

Aldose reductase inhibition by AS-3201 in sural nerve from patients with diabetic sensorimotor polyneuropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613255

4 September 2018

Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: a 52-week multicenter placebo-controlled double-blind parallel group study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613255

4 September 2018

Aldose reductase inhibition ameliorates pupillary light reflex and F-wave latency in patients with mild diabetic neuropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613255

4 September 2018

The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2613255

4 September 2018

The effects of age and diabetes mellitus on nerve function

1 reference

https://pubmed.ncbi.nlm.nih.gov/18644069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18644069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mexiletine for treatment of chronic painful diabetic neuropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18644069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18644069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Withdrawal of the aldose reductase inhibitor tolrestat in patients with diabetic neuropathy: effect on nerve function. The Tolrestat Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/18644069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multicentre trial of the aldose-reductase inhibitor, tolrestat, in patients with symptomatic diabetic neuropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18644069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diabetic neuropathies

1 reference

https://pubmed.ncbi.nlm.nih.gov/18644069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy. Zenarestat Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/18644069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

International conference on harmonisation; guidance on statistical principles for clinical trials; availability--FDA. Notice

1 reference

https://pubmed.ncbi.nlm.nih.gov/18644069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1464-5491.2008.02490.X

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37035477&oldid=2166533323"